Ramucirumab plus paclitaxel for gastric cancer in China

被引：2
作者：
Yoon, Harry H. [1 ]
机构：
[1] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2021年 / 6卷 / 12期
关键词：
DOUBLE-BLIND; PHASE-III; ADENOCARCINOMA; CHEMOTHERAPY; BEVACIZUMAB; RAINBOW; TRIAL;
D O I：
10.1016/S2468-1253(21)00342-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：975 / 976
页数：2
相关论文
共 11 条
  • [1] Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
    Allemani, Claudia
    Matsuda, Tomohiro
    Di Carlo, Veronica
    Harewood, Rhea
    Matz, Melissa
    Niksic, Maja
    Bonaventure, Audrey
    Valkov, Mikhail
    Johnson, Christopher J.
    Esteve, Jacques
    Ogunbiyi, Olufemi J.
    Azevedo e Silva, Gulnar
    Chen, Wan-Qing
    Eser, Sultan
    Engholm, Gerda
    Stiller, Charles A.
    Monnereau, Alain
    Woods, Ryan R.
    Visser, Otto
    Lim, Gek Hsiang
    Aitken, Joanne
    Weir, Hannah K.
    Coleman, Michel P.
    [J]. LANCET, 2018, 391 (10125) : 1023 - 1075
  • [2] Screening for gastric cancer in China: Advances, challenges and visions
    Fan, Xiaohan
    Qin, Xiangxiang
    Zhang, Yang
    Li, Zhexuan
    Zhou, Tong
    Zhang, Jingying
    You, Weicheng
    Li, Wenqing
    Pan, Kaifeng
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2021, 33 (02) : 168 - 180
  • [3] Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.21492, 10.3322/caac.20115, 10.3322/caac.20107]
  • [4] Kang YK, 2019, ANN ONCOL, V30
  • [5] Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
    Li, Jin
    Qin, Shukui
    Xu, Jianming
    Xiong, Jianping
    Wu, Changping
    Bai, Yuxian
    Liu, Wei
    Tong, Jiandong
    Liu, Yunpeng
    Xu, Ruihua
    Wang, Zhehai
    Wang, Qiong
    Ouyang, Xuenong
    Yang, Yan
    Ba, Yi
    Liang, Jun
    Lin, Xiaoyan
    Luo, Deyun
    Zheng, Rongsheng
    Wang, Xin
    Sun, Guoping
    Wang, Liwei
    Zheng, Leizhen
    Guo, Hong
    Wu, Jingbo
    Xu, Nong
    Yang, Jianwei
    Zhang, Honggang
    Cheng, Ying
    Wang, Ningju
    Chen, Lei
    Fan, Zhining
    Sun, Piaoyang
    Yu, Hao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (13) : 1448 - +
  • [6] Subgroup analysis of East Asians in RAINBOW: A phase 3 trial of ramucirumab plus paclitaxel for advanced gastric cancer
    Muro, Kei
    Oh, Sang Cheul
    Shimada, Yasuhiro
    Lee, Keun-Wook
    Yen, Chia-Jui
    Chao, Yee
    Cho, Jae Yong
    Cheng, Rebecca
    Carlesi, Roberto
    Chandrawansa, Kumari
    Orlando, Mauro
    Ohtsu, Atsushi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (03) : 581 - 589
  • [7] Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
    Ohtsu, Atsushi
    Shah, Manish A.
    Van Cutsem, Eric
    Rha, Sun Young
    Sawaki, Akira
    Park, Sook Ryun
    Lim, Ho Yeong
    Yamada, Yasuhide
    Wu, Jian
    Langer, Bernd
    Starnawski, Michal
    Kang, Yoon-Koo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (30) : 3968 - 3976
  • [8] Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)
    Shen, Lin
    Li, Jin
    Xu, Jianming
    Pan, Hongming
    Dai, Guanghai
    Qin, Shukui
    Wang, Liwei
    Wang, Jinwan
    Yang, Zhenzhou
    Shu, Yongqian
    Xu, Ruihua
    Chen, Lei
    Liu, Yunpeng
    Yu, Shiying
    Bu, Lilian
    Piao, Yongzhe
    [J]. GASTRIC CANCER, 2015, 18 (01) : 168 - 176
  • [9] Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
    Wilke, Hansjochen
    Muro, Kei
    Van Cutsem, Eric
    Oh, Sang-Cheul
    Bodoky, Gyoergy
    Shimada, Yasuhiro
    Hironaka, Shuichi
    Sugimoto, Naotoshi
    Lipatov, Oleg
    Kim, Tae-You
    Cunningham, David
    Rougier, Philippe
    Komatsu, Yoshito
    Ajani, Jaffer
    Emig, Michael
    Carlesi, Roberto
    Ferry, David
    Chandrawansa, Kumari
    Schwartz, Jonathan D.
    Ohtsu, Atsushi
    [J]. LANCET ONCOLOGY, 2014, 15 (11) : 1224 - 1235
  • [10] Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised multicentre, double-blind, phase 3 trial
    Xu, Rui-Hua
    Zhang, Yanqiao
    Pan, Hongming
    Feng, Jifeng
    Zhang, Tao
    Liu, Tianshu
    Qin, Yanru
    Qin, Shukui
    Yin, Xianli
    Liu, Baorui
    Ba, Yi
    Yang, Nong
    Voon, Pei Jye
    Tanasanvimon, Suebpong
    Zhou, Chan
    Li Zhang, Wan
    Shen, Lin
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (12): : 1015 - 1024
12